Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.
2.

Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.

Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.

Exp Cell Res. 2003 Oct 1;289(2):265-74.

PMID:
14499627
4.

Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.

Okuyama T, Ishihara S, Sato H, Rumi MA, Kawashima K, Miyaoka Y, Suetsugu H, Kazumori H, Cava CF, Kadowaki Y, Fukuda R, Kinoshita Y.

J Lab Clin Med. 2002 Aug;140(2):92-102.

PMID:
12228765
6.
7.

A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation.

Abrahao AC, Castilho RM, Squarize CH, Molinolo AA, dos Santos-Pinto D Jr, Gutkind JS.

Oral Oncol. 2010 Dec;46(12):880-7. doi: 10.1016/j.oraloncology.2010.09.005.

8.

The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach.

Araki H, Ukawa H, Sugawa Y, Yagi K, Suzuki K, Takeuchi K.

Aliment Pharmacol Ther. 2000 Apr;14 Suppl 1:116-24.

9.

Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.

Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M.

J Exp Ther Oncol. 2008;7(4):299-312.

PMID:
19227010
10.

Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.

Takeuchi K, Ukawa H, Furukawa O, Kawauchi S, Araki H, Sugimoto Y, Ishikawa A, Ushikubi F, Narumiya S.

J Physiol Pharmacol. 1999 Jun;50(2):155-67.

PMID:
10424714
12.

EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.

Jadhav V, Jabre A, Lin SZ, Lee TJ.

J Cereb Blood Flow Metab. 2004 Dec;24(12):1305-16.

13.

Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.

Doherty GA, Byrne SM, Molloy ES, Malhotra V, Austin SC, Kay EW, Murray FE, Fitzgerald DJ.

BMC Cancer. 2009 Jun 26;9:207. doi: 10.1186/1471-2407-9-207.

14.

Involvement of postsynaptic EP4 and presynaptic EP3 receptors in actions of prostaglandin E2 in rat supraoptic neurones.

Shibuya I, Setiadji SV, Ibrahim N, Harayama N, Maruyama T, Ueta Y, Yamashita H.

J Neuroendocrinol. 2002 Jan;14(1):64-72.

PMID:
11903814
15.

Mechanisms of cytosolic Ca2+ suppression by prostaglandin E2 receptors in rat melanotrophs.

Nagata T, Harayama N, Sasaki N, Inoue M, Tanaka K, Toyohira Y, Uezono Y, Maruyama T, Yanagihara N, Ueta Y, Shibuya I.

J Neuroendocrinol. 2003 Jan;15(1):33-41.

PMID:
12535167
16.
17.
18.

Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts.

Shoji M, Tanabe N, Mitsui N, Tanaka H, Suzuki N, Takeichi O, Sugaya A, Maeno M.

Life Sci. 2006 Mar 20;78(17):2012-8.

PMID:
16289620
19.
20.
Items per page

Supplemental Content

Support Center